THE BIOTECH PRIMER takes an in-depth look at the biotech industry, and in particular, the science that drives it. From cell structure to protein structure; gene expression to genetic variation and genetic engineering; the human immune response to the production of antibodies for biotech application; and finally drug discovery, drug development, and biomanufacturing-we discuss the key concepts and technologies that impact current biotechnology developments. This book will support your growth as a biotechnology professional. Although the industry itself is constantly changing, these fundamental concepts upon which it is built will remain important for years to come-and decision-makers who understand these fundamentals will be better able to evaluate and predict new trends.More than anything else, we hope that your understanding of the science behind biotechnology will serve to increase your enthusiasm for this exciting and truly life-changing industry. The future is here-be a part of it.

Now presented in large format, the new Schmid is the ideal primer in biotechnology. The two-page layout with one page being a full color figure and the opposite page being explanatory text is the ideal combination between rapid visual-based learning with in depth information.

The Biotech Primer takes an in-depth look at the biotech industry, and in particular, the science that drives it. From cell structure to protein structure; gene expression to genetic variation and genetic engineering; the human immune response to the production of antibodies for biotech application; and finally drug discovery, drug development, and biomanufacturing: we discuss the key concepts and technologies that impact current biotechnology developments. This book will support your growth as a biotechnology professional. Although the industry itself is constantly changing, these fundamental concepts upon which it is built will remain important for years to come: and decision-makers who understand these fundamentals will be better able to evaluate and predict new trends. More than anything else, we hope that your understanding of the science behind biotechnology will serve to increase your enthusiasm for this exciting and truly life-changing industry. The future is here and you should be a part of it.

"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--

This self-teaching guide explains the basic concepts and fundamentals in all the major subtopics of biotechnology. The content advances logically from the basics of molecular and cellular biology to more complex topics such as DNA, reproductive cloning, experimental procedures, infectious diseases, immunology, the Human Genome Project, new drug discoveries, and genetic disorders.

A one-stop source for investing in biotech-with detailed coverage of the science, the business, the players, and the strategies for one of today's most promising (and volatile) industries To invest in biotech is to invest in the future, and as such, investors need to learn the nuances of the science they're putting their money on. The core asset of biotech companies is knowledge, and sound investment decisions are impossible without an understanding of this complex science. That's where The Biotech Investor's Bible fits in. This much-needed, one-of-a-kind resource simplifies the complex science surrounding the business of biotech and clarifies subtle distinctions within the context of their financial repercussions. The book explains the basics of genetics, patents, and therapies; and teaches investors how to value biotech companies and their state-of-the art products and technology. The Biotech Investor's Bible offers an informative summary of the relatively short history of the industry and provides a comprehensive review of various industry sectors.